Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

and central sleep apnea (CSA). In both cases, CPAP machines and sleep masks are often recommended as treatment. Research estimates close to a billion people worldwide experience OSA, in mild to ...

July 23, 2024 — Nearly 40 million adults in the U.S. have sleep apnea, and more than 30 million of them use a continuous positive airway pressure (CPAP) machine while sleeping. However ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

Diagnosis involves polysomnography, and treatment options include CPAP machines ... These are obstructive, central and mixed sleep apnea. Let’s see what each one is about.

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

“A 10-year-old with uncontrolled central sleep apnea is about 200 times more likely ... undergoing continuous positive airway pressure (CPAP)/bi-level positive airway pressure therapy had ...

Since sleep apnea affects nearly a billion people worldwide, and using a CPAP machine (the standard treatment for sleep apnea) can be cumbersome, the approval by the Food and Drug Administration ...